IGM Biosciences Inc logo

IGMS

IGM Biosciences Inc

$22.81

Earnings Summary

Revenue
$0Mn
Net Profits
$-51.89Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

IGM Biosciences Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, IGM Biosciences Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

IGM Biosciences Inc’s net profit fell -63.99% since last year same period to $-51.89Mn in the Q1 2022. On a quarterly growth basis, IGM Biosciences Inc has generated -2.47% fall in its net profits since last 3-months.

Net Profit Margins:

IGM Biosciences Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2022. On a quarterly growth basis, IGM Biosciences Inc has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the IGM Biosciences Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.94
EPS Estimate Current Year
-0.94

Highlights

EPS Estimate Current Quarter:

IGM Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.94 - a 41.61% jump from last quarter’s estimates.

EPS Estimate Current Year:

IGM Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.94.

Key Ratios

Key ratios of the IGM Biosciences Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-1.53
Return on Assets (ROA)
-0.28
Return on Equity (ROE)
-0.59
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

IGM Biosciences Inc’s earning per share (EPS) fell -61.05% since last year same period to -1.53 in the Q1 2022. This indicates that the IGM Biosciences Inc has generated -61.05% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. IGM Biosciences Inc’s return on assets (ROA) stands at -0.28.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. IGM Biosciences Inc’s return on equity (ROE) stands at -0.59.

Dividend Per Share (DPS):

IGM Biosciences Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-09
-1.61
-1.53
4.97%

Company Information

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Organisation
IGM Biosciences Inc
Headquarters
Mountain View, California, United States
Employees
107
Industry
Health Technology